Yes, cannon...Bruce put much more time, effort, and intelligence into his analysis of the market opportunity than the SCNetwork "analyst" did.
Personally I think trying to estimate the market for a universal cancer marker with 90%+ accuracy is so silly it's not even funny. It's a pure jerk-off excercise: "is it a billion or $500 million" -- give me a frigging break. IT'S MASSIVE! ENOUGH SAID! I wish that guy spent more time analyzing the data and BOCX's methodology for obtaining the data as published as part of their response to the SEC -- rather than jerking himself off about Astrazeneca and the general oncology market opportunity. That's just me though...the question in this stock is not how big the market is, but how credible is the data. Once the world believes our data the fat lady has sung.
DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.
